Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
No Borrowings in the last few periods;
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2026 is -21.74% vs 39.39% in Mar 2025
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2026 is -2.17% vs 33.18% in Mar 2025
Compare Balance Sheet Results of Brawn Biotech
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
3.00
3.05
-0.05
-1.64%
Share Warrants & Outstandings
Total Reserve
1.34
0.84
0.50
59.52%
Shareholder's Funds
4.34
3.90
0.44
11.28%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.00
0.00
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
-1.45
0.00
-1.45
0.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
1.29
0.00
1.29
0.00%
Long Term Provisions
0.06
0.00
0.06
0.00%
Total Non-Current Liabilities
-0.11
0.00
-0.11
0.00%
Current Liabilities
Trade Payables
14.41
0.01
14.40
144,000.00%
Other Current Liabilities
0.70
0.36
0.34
94.44%
Short Term Borrowings
0.00
0.00
0.00
0.00%
Short Term Provisions
0.06
0.09
-0.03
-33.33%
Total Current Liabilities
15.17
0.46
14.71
3,197.83%
Total Liabilities
19.40
4.36
15.04
344.95%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
1.05
0.01
1.04
10,400.00%
Less: Accumulated Depreciation
0.69
0.00
0.69
0.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.36
0.01
0.35
3,500.00%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.00
0.00
0.00%
Long Term Loans & Advances
0.00
1.73
-1.73
-100.00%
Other Non Current Assets
1.92
0.00
1.92
0.00%
Total Non-Current Assets
2.28
1.73
0.55
31.79%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
10.06
0.28
9.78
3,492.86%
Sundry Debtors
3.55
2.21
1.34
60.63%
Cash and Bank
0.28
0.05
0.23
460.00%
Other Current Assets
0.17
0.00
0.17
0.00%
Short Term Loans and Advances
3.06
0.08
2.98
3,725.00%
Total Current Assets
17.12
2.62
14.50
553.44%
Net Current Assets (Including Current Investments)
1.95
2.16
-0.21
-9.72%
Total Current Assets Excluding Current Investments
17.12
2.62
14.50
553.44%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
19.40
4.36
15.04
344.95%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
0.00
0.00
0.00
0.00%
Book Value per share (adjusted)
14.46
12.76
1.70
13.32%
Annual - Borrowings
No Borrowings in the last few periods
No Borrowings in the last few periods;
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 0.36 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -21.74% vs 39.39% in Mar 2025
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 17.12 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -2.17% vs 33.18% in Mar 2025
